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Abstract
Chronic venous diseases of the lower limbs are one of the common and disabling condi‐
tions with clinical signs and symptoms ranging from spider veins, to varicose veins or 
even to venous ulceration, effecting patient’s quality of life negatively, particularly in 
relation to the domains of pain, physical function and mobility. It is not only a serious 
medical condition but also an undeniable physical and psychosocial problem and has 
a severe impact on a patient’s quality of life. Quality of life is defined as individuals’ 
perception of their position in life and refers to the patient’s ability to enjoy normal life 
activities. It is a common and subjective term that has a number of dimensions described 
as patient‐reported outcomes. There are numerous factors that affect person’s quality of 
life negatively. Some of those are social relationships, economic status, physical health, 
psychological status, environmental conditions (living place or work), pain and espe‐
cially chronic diseases. We conducted a review about quality of life in chronic venous 
diseases of the lower limbs to identify how person’s quality of life is affected. Therefore, 
this chapter will focus on the effect of the chronic venous diseases on the person’s quality 
of life.
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1. Introduction
Chronic venous disorders (or in other name chronic venous diseases) (CVDs) are widespread 
problem and can vary from asymptomatic insufficiency of venous valves to chronic leg ulcers 
[1]. The importance of venous disorders is determined by the socioeconomic influence of dis‐
ease according to its severity and the number of affected person [2]. Although it does vary, it 
is revealed that the venous disorders have high prevalence in the community. Approximately 
23% of the adult population have varicose veins and 17% have chronic venous insufficiency 
(CVI) (which is one of the CVD), in all age groups. In addition, it clinically varies from mini‐
mal lower leg edema to severe leg ulcers [3].
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CVI is a condition that the blood flow within the veins is insufficient, resulting in pooling of 
blood in the veins, especially in the lower limbs. It can be resulted from by several venous dis‐
orders, particularly in chronic situations. It is characterized by permanent lower limb venous 
hypertension as a result of venous reflux and/or occlusion and insufficient calf muscle pump 
function [4]. It represents severe phase of CVD and denotes some symptoms such as edema, 
skin changes, and venous ulcer [5].
CVI is commonly characterized by a condition including diseases in the venous system of the 
lower extremities [6]. There are a lot of reports about prevalence in CVI, and its variation is 
very large. This difference may result from the differences in the definition of venous insuf‐
ficiency and in the methods used for clinical evaluation of the signs and symptoms [7]. There 
is a study reported that CVI varies between 1 and 17% in men and 1 and 40% in women [8]. 
However, it is predicted to be as high as 50% in the general population especially in industrial 
countries [2, 9].
To understand effects of CVI on the quality of life and health outcomes, it is necessary to 
know the venous anatomy and pathophysiological mechanism. Therefore, we first decided to 
begin giving information about the anatomy and pathophysiology of the disease.
2. Anatomy of the venous system
Functionally, the peripheral venous system is assumed as a reservoir to store blood and as a 
canal to return blood to the heart [10]. Depending on activating peripheral muscle pumps and 
a series of valved conduits to return blood against gravity, the venous system in the lower 
limbs is more complex than the arterial system [11]. The deep, superficial and most of per‐
forating veins include bicuspid valves opening just one direction [12]. Veins are consisted of 
three layers, which are intima, media, and adventitia as the similar arteries, although having 
much thinner vessel wall than arteries [13]. In addition, they have a weaker muscular layer 
and less elastic tissue when compared with arteries [14].
To classify the veins in the lower limbs, it is considered the relationship between veins and 
the muscular fascia and location in either the superficial or deep compartment. In this con‐
text, they are separated into three groups. These include the deep veins, the superficial veins 
and the perforating veins. The deep veins are located between the large muscle groups of 
the lower limb inside the myofascial compartments beneath the muscular fascia [15, 16]. The 
superficial veins are located above the deep fascia and drain the microcirculation of cutaneous 
tissue. The perforating veins are responsible for connection between the superficial and deep 
veins. There is also another group of veins named as communicating veins connecting veins 
within the same system (deep to deep, superficial to superficial) [15]. In normal situations, 
muscles contraction generates pressure during contractions in the fascial compartment and 
this is directly transferred to the veins. Whereby, venous blood flow is directed to the heart 
via competent valves in the venous system [16]. When muscle pump relaxes, blood begins 
refill to the deep venous system. Veins become swollen as the vein is filled by antegrade flow 
in prolonged standing positions. Therefore, the valves within the veins begin to open and 
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pressure to rise. By dint of muscle pump contraction, the veins begin to discharge and venous 
pressure decrease [10].
In the lower limbs, as we mentioned above, contraction of the calf muscle provides a signifi‐
cant mechanism to push and direct blood flow within the veins toward the heart. Blood in 
the deep veins starts to empty throughout the muscle contraction, and blood flows from the 
superficial to the deep veins via the perforating veins. Therefore, the pressure in the venous 
system decreases during ambulation [17]. Venous reflux or obstruction at any time in super‐
ficial or deep veins is related to venous disease and the clinical manifestations of CVI. An 
increased pressure in the venous pressure causes a retrograde elevation of pressure into the 
venules (thinner veins) of the skin. This leads to continuous elevated ambulatory venous 
 pressures (as known commonly venous hypertension) that have been related to development 
of leg ulcers in advanced stages [18].
3. Pathophysiology of venous disorders
Rising venous pressure and occurring impairment in blood flow by several mechanisms lead 
to develop venous pathology [19]. It may resulted from valvular incompetence in superficial, 
deep or perforator veins, venous tributaries, or obstruction in veins, or a combination of these 
mechanisms [10]. Congenital causes, repetitive infections, trauma or inflammation resulted 
from deep vein thrombosis (DVT) may damage the valves. Obesity, pregnancy, a pelvic mass 
and previous history of DVT may cause obstruction in veins [20]. Abnormal formation of 
veins and arteries as a congenital disease (arteriovenous malformations) [21] or insufficient 
of the calf muscle pump caused by fatigue, immobility, or decreased ankle mobility result‐
ing from neuromuscular or orthopedic diseases also contribute to this process [22]. Damage 
the valves results in reverse flow or leakage in the closed valves [23]. In addition, high pres‐
sure begin to enter into superficial veins, when the failure of valves in the saphenofemoral 
and saphenopopliteal junctions (between to the deep and superficial systems) emerges. It can 
also enter the superficial system due to malfunction of the perforator valves. As the conse‐
quence of this situation, veins start to dilate and varicose veins begin to form and Spread to 
the extremity [10].
In normal conditions, most of perforator veins are inactive. When the venous hypertension 
develops, they begin to open, and leakage of the blood occurs from deep to superficial veins 
[24]. Changing in the microcirculation contributes to the macrocirculatory hemodynamic dis‐
turbances [25]. If venous hypertension is not treated, it causes changes in the skin with hyper‐
pigmentation, fibrosis in subcutaneous tissue and eventually ulceration [10].
4. Risk factors
There are some risk factors are defined leading to development of CVI such as heredity, age, 
female sex, obesity, pregnancy, prolonged standing conditions (Figure 1).
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Several studies have revealed older age as the most important risk factor for CVI. It is more 
common especially in female adults than male [3, 26]. However, in the Edinburgh Vein 
research, it has to be reported that varicose veins were more common among males in the 
general population [27]. Obesity is another risk factor leading to CVI. It is stated that having 
more than 30 a body mass index (BMI) increases the risk for CVI significantly in both sexes, 
especially in males [28]. In addition, it is found that a relationship between severe obesity 
(BMI ≥ 40) and increased limb symptoms without anatomic evidence of CVD. Therefore, it 
is suggested that the obesity itself is a factor, which contributes to the venous insufficiency 
[29, 30]. A positive family history, also, is shown to be a predisposing factor for varicose 
veins or venous disease [28, 31].
5. Symptoms
Symptomatic varicose veins are not assumed as a life‐threatening situation, but it is generally 
progressive, and if progress, it may result in ulceration on the skin [32]. As we emphasized, 
CVI is a chronic disease seen with the many symptoms ranging from aching of the legs, vari‐
cose veins, telangiectasia, muscle cramps, swelling, pruritus, fatigue, throbbing, itching of the 
skin, to sense of heaviness in lower limbs [33] (Figures 2 and 3).
The symptoms of CVI cause considerable morbidity in patients, decreasing on quality of life 
(QoL) [34]. It is reported that the symptoms are worse especially in women [35]. Some symp‐
toms are exacerbated by the prolonged standing position such as fatigue, heaviness and pain 
[36]. Therefore, when the patient is being evaluated, these symptoms should questioned with 
daily activities and work, especially in patients who must be stand for a long periods of time. 
In general, symptoms are worse at the end of the day. Exercise for lower limbs, mobilization 
and leg elevation may help relief in symptomatic signs [37].
CVDFemalesex
Heredity
Age Pregnancy
Obesity
Prolonged
standing
posion
Figure 1. Risk factors of chronic venous disorders.
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In patients developing chronic outflow obstruction, venous claudication may occur dur‐
ing activities such as walking or climbing stairs. It is also stated that there is an association 
between QoL scores to severity of disease. Patients indicating the more severe signs and 
symptoms reported the worse QoL scores [37].
Symptoms of Chronic Venous 
Disorders
Varicose veins
Aching of the legs
Telangiectasia
Muscle cramps
Swelling
Pruritus
Fague
Throbbing
Itching of the skin
Sense of heaviness in lower limbs
Figure 2. Symptoms of chronic venous disorders.
A
B C
Figure 3. Clinical signs of chronic venous disorders: A: skin changes, B: venous ulcer, C: telangiectasia and reticular veins.
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6. Classification
CVI, due to the nature of the disease, presents various signs and symptoms, and this creates 
a significant challenge to determine severity of disease, to interpret and compare published 
reports in the literature, objectively. It may be classified using clinical, anatomical, hemody‐
namic, or patient reported criteria. The challenges resulted from inconsistent reports emerged 
an applicable and standardized classification system for venous disease [38].
Although there are some classification methods to determine and classify severity of disease, 
Clinical Etiological Anatomical Pathophysiological (CEAP) classification and Venous Clinical 
Severity Score (VCSS) are the most using system among them.
6.1. Clinical etiological anatomical pathophysiological (CEAP) classification
The CEAP classification was developed in 1994 the American Venous Forum to describe the 
severity and etiology of lower limb venous disease, and it was revised in 2004. Thanks to 
the adoption of this system, correlation among different studies and clinics, and meaningful 
communication about CVD could be done easily, in a standard way [39]. It serves as a sys‐
tematic guide in the routine clinical examination of patients with an accurate diagnosis. In the 
classification of CEAP, there are four parameters. These are clinical indications (C), etiologic 
factors (E), anatomic dispersion (A), and underlying pathophysiologic manifestations (P) [40]. 
Detailed information is given in Table 1.
There are two version of CEAP: basic version and extended version. The basic version is developed 
for practical intent. It does not require training for using it and is commonly used in day‐to‐day 
care. In addition, its primary aim is using for clinical application; however, it can be used as well 
as for the purpose of research. The CEAP classification system is an objective and well‐constructed 
CEAP classification system
Clinical Etiologic Anatomic Pathophysiologic
C
0
 : There is no any signs of 
venous disease
Ec : Congenital As : Superficial veins Pr : Reflux
C
1
 : Telangiectases or 
reticular veins
C
2
 : Varicose veins Ep : Primary Ap : Perforator veins Po : Obstruction
C
3
 : Edema
C
4a
 : Pigmentation or 
eczema on the skin
Es : Secondary (post‐
thrombotic, post‐traumatic)
Ad : Deep veins Pr,o : Reflux and 
obstruction
C
4b
 : Lipodermatosclerosis 
or atrophie blanche
C
5
 : Healed venous ulcer En : There is no cause 
determined
An : There is no venous 
location identified
Pn : There is no venous 
pathophysiology 
determined
C
6
 : Active venous ulcer
Table 1. CEAP classification system.
Well-being and Quality of Life - Medical Perspective60
instrument, although it has shortage in detecting key symptoms of venous disease. It is reported 
that the deviations of CEAP scores between different physicians are not significant [41].
In the study, conducted by Kahn et al. [37], it is found that clinical values of CEAP in 
patients with venous diseases were significantly associated with generic and disease‐spe‐
cific QoL. Their results emphasized that CVD has an adverse effect on QoL, proportionally 
severity of disease. In addition, it is showed that the variables of sex, age, country, duration 
of CVD, BMI, education level, and presence comorbidities were associated with QoL scores.
6.2. Venous severity scoring
Although there are many reports that proving the CEAP classification is a useful instrument in 
classifying venous diseases, there is need more detailed information concerning severity and 
longitudinal changes of disease in patient during treatment [42]. In the basis of this thought, 
the American Venous Forum developed Venous Severity Scoring (VSS) from ingredients of 
the CEAP for measurement of disease severity, in 2000 [43]. The VSS includes three com‐
ponents about scoring of disease. These are the Venous Disability Score (VDS), the Venous 
Segmental Disease Score (VSDS) and the Venous Clinical Severity Score (VCSS).
VDS is a modification of the original CEAP classification, which is providing disability 
level, and it evaluates the functional impact of CVD in daily activities. VSDS considers both 
The venous clinical severity scoring
Qualification Absent: 0 Mild: 1 Moderate: 2 Severe: 3
Sense of discomfort, 
Pain, aching, fatigue 
heaviness
No Sometimes, it does 
not reflect in Daily 
activities
Daily, it does not 
affect daily activities
Daily, it restricts 
most of activitiy
Varicose veins No Few and scattered Confined to calf or 
thigh
Involve calf and thigh
Venous edema No Restricted foot and 
ankle
Spreads above ankle 
but don not pass the 
knee
Extends to knee or 
above the knee
Pigmentation of the skin No or focal Restricted in 
perimalleolar area
Diffuse over lower 
third of calf
Diffuse more than 
lower third of calf
Inflammation No Restricted in 
perimalleolar area
Diffuse over lower 
third of calf
Diffuse more than 
lower third of calf
Skin induration No Restricted in 
perimalleolar area
Diffuse over lower 
third of calf
Diffuse more than 
lower third of calf
Number of active ulcers 0 1 2 >2
Duration of ulcer Absent Less than 3 months Between 3 months to 
1 year
Unhealing ulcer more 
than 1year
Size of ulcer Absent Diameter <2 cm Diameter 2–6 cm Diameter >6 cm
Compression therapy Not used Intermittant Most days Every day, mostly
Table 2. Venous clinical severity scoring.
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anatomical and pathological aspects of CVD to provide score about obstruction and reflux. 
VCSS was designed the aim of obtaining the severity of venous disease. It evaluates totally 
10 clinical parameters, and each item scores graded from absent (score 0) to severe (score 3) 
[43], which is shown in Table 2. The VCSS provides more reliable information about severity 
of disease in patient’s routine activities [44]. It is mentioned that the VCSS scores are associ‐
ated with QoL measurements [41].
7. Quality of life
The term ‘Quality of life’ (QoL) is a broad multidimensional concept that usually includes 
subjective evaluations of both positive and negative aspects of life and affected by the 
culture, individuals’ goals, expectations, spirituality, standards and concerns [45, 46]. In 
another way, it is defined as individuals’ perception of their position in life and refers to 
the patient’s ability to enjoy normal life activities [46]. It observes life satisfaction, includ‐
ing everything from physical health, family, education, employment, wealth, religious 
beliefs, finance and the environment [47]. Therefore, the mean of QoL varies among differ‐
ent people.
There is a consensus in the idea that patients’ sights are not stable, and it shifts according 
to their expectations and perceptions. However, these parameters effecting psychological 
aspects of disease and degree of symptoms are sometimes underestimated in clinical prac‐
tice. In order to obtain accurate meaning of QoL in clinical medicine and trials, it is necessary 
to distinguish between QoL in its more general sense [48]. Consequently, the term ‘health‐
related quality of life’ (HRQoL) is derived to obtain more reliable clinical outcomes. Thanks 
to this idea, clinicians can justify the suitability and cost‐effectiveness of the treatment they 
recommend [49].
The quality of life has subjective and objective indicators, which reflect patient’s physical 
and psychological aspects [50] (Figure 4). Objective parameters such as income and physical 
function can be used in assessing quality of life, but they do not give better opinion about per‐
ceiving and experiencing individual’s lives. They are better for demonstrating of individual’s 
subjectively perceived QoL, which is critical factor in deciding for treatment and health care 
policy [51–53]. Subjective evaluations are including psychological domain of pleasure, gen‐
eral happiness and well‐being mostly useful to define the experience of life [53] and effective‐
ness of treatment [54].
There are two basic categories of QoL surveys as generic and disease‐specific (Figure 5). Both 
of generic‐and disease‐specific questionnaires should be used in evaluating QoL, as long as 
surveys that is reliable, valid, and responsive [55]. For evaluating global sense of well‐being 
and obtaining a subjective measure in efficacy of treatment, generic tools are widely used, 
and they are appropriate to provide information about QoL in a wide spectrum of disease 
[56]. Furthermore, in the population with varied circumstances, they enable comparison of 
measures across populations. However, disease‐specific measures are more sensitive in defin‐
ing effect of treatment and changes in the disease over time [55].
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In particular, in recent years, there is an increasing view that patient‐reported QoL is a signifi‐
cant way for evaluating outcomes, especially changes in disease. For chronic conditions such 
as CVI, evaluation of QoL can provide useful information about burden of disease if it does 
not captured well by the physician based on other measures [55, 57]. Although mortality rates 
Quality of Life
Subjecve 
parameters
Pleasure and 
general 
happiness
Well-being
Objecve 
parameters
Physical and 
menthal funcon
level of income
Figure 4. Parameters of quality of life.
Generic Instruments
• The 36-Item Short Form Health Survey
• Nongham Health Profile
• EuroQoL, 5D
• Sickness Impact Profile 
Disease-Spesific Instruments
• Chronic Venous Insufficiency 
Quesonnaire
• Venous Insufficiency Epidemiological 
and Economic Study
• Aberdeen Varicose Vein Quesonnaire
• Specific Quality of life and Outcome 
Response – Venous 
• Assessment of Burden in Chronic 
Venous Disease
• Charing Cross Venous Ulceraon 
Quesonnaire
Figure 5. Generic and disease‐specific questionnaires.
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are low in some diseases such as CVI, patient satisfaction including resolution of symptoms 
and improvement in HRQoL is recognized as significant treatment outcome measures [58].
As we mentioned above, CVI is a common circulatory disorder that impairs the return of 
blood to the heart. It mainly affects the legs, causing varicose veins, thrombosis, edema, and 
ulceration, which affects QoL. There are many generic and disease‐specific QoL assessment 
tools using in CVI. We aimed to explain these instruments, particularly the most widely used 
in clinical trials.
7.1. Generic instruments
Generic instruments intend for evaluating general QoL, regardless of the diseases or situation 
of the patient. They usually can be used in healthy population, too [48].
7.1.1. The 36‐item short form health survey
A widely used and the most popular well‐validated generic quality‐of‐life instrument is the 
36‐Item Short Form Health Survey (SF‐36) [59]. It is designed to assess generic health status, 
which is not specific to any age, illness or treatment option [48]. The SF‐36 is developed in 
1993 using the questions in two categories as physical health and mental health (Figure 6). 
The category of physical health indicates the patient’s level of functioning, and mental health 
indicates of well‐being [56]. It contains eight items, which is multidimensional, measuring 
overall health, functional status and well‐being [60]. Besides these items, there are two tran‐
sition question related to general health and perception of individual’s health. These are 
‘Compared to one year ago, how would you rate your general health now?’ and ‘In general, 
would you say your health is: (excellent, very good, good, fair, poor)?’, respectively [48]. It 
is stated that items in the SF‐36 detect negative states of health besides the positive aspect; 
however, some of these dimensions are similar to those in the Nottingham Health Profile [61]. 
The survey generates a score between 0 and 100, and 0 point indicates worst, 100 indicates 
best general health perception [60].
Being applicable for a broad range of diseases and thoroughly valid and reliable for measur‐
ing QoL are advantages of the SF‐36. It is found to be clinically and psychometrically consis‐
tent [62] and completed approximately in 5 min, which is admissible in clinical practice [41].
The SF‐36 has demonstrated to be a good fit for assessing QoL in the population with CVD. In 
the studies, it is shown that there is a correlation between the physical component of question‐
naire in the patients with CVD and severity of illness. In addition, the strong correlation between 
all subdomains of the physical components and disease severity measured by the CEAP classifi‐
cation is demonstrated in the literature. However, for the mental component, it is not presented. 
Correlations between vitality [63] and mental health [64] are poor and inconsistent [38].
Kaplan et al. [63], in their study, used SF‐36 to evaluate QoL in patients with CVD, and they 
found that there was significant correlation between physical component of QoL and severity 
of venous disease. They also reported that CVD in the lower extremities has a significant effect 
on physical health.
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Darvall et al. [34] conducted a study including 284 patients to determine whether there is 
any relationship between symptoms in lower limb and generic HRQoL in patients with 
untreated varicose veins. To obtain data they used SF‐12 (shortened version of SF‐36) and 
CEAP. In conclusion, they presented that both physical and mental HRQoL are meaning‐
fully worse in patients with lower limb symptoms regardless of clinical grade of disease. 
Furthermore, they emphasized that generic HRQoL instruments can be used for comparing 
effect of treatments.
7.1.2. Nottingham Health Profile
Apart from SF‐36, the Nottingham Health Profile (NHP) is another generic instrument 
designed with a view to measure QoL. Emotional, social and physical health parameters, 
which are affected by the disease, can assessed with the NHP for a wide spectrum of ill‐
ness and situation. It measures subjective health status in sleep, emotional reactions, physical 
mobility, social isolation, pain, and fell of energy. The questions in each area are answered by 
‘yes’ or ‘no’ [65]. An example for each section is given in Table 3.
In a study, the SF‐36 is compared with the NHP in patients with of chronic limb ischemia in 
different degrees. As a result of this study, it is demonstrated that the SF‐36 has more internal 
consistency among patients with mild ischemic symptoms, but the NHP has greater sensitiv‐
ity to change in patients with more severe ischemia [66].
The NHP is a short questionnaire, and easy to complete. In the NHP, expressions and sen‐
tences are not complicated and confounding. It is used frequently both in medical (although 
it was not designed for that purpose) and non‐medical situations to evaluate general health 
status of individual. However, it is less sensitive in detecting the minor changes in health 
status and identifying particular problems [48].
Physical Health
Physical funconing
Physical role
Pain
General health
Mental Health
Vitality
Social funconing
Emoonal role
Mental health
Figure 6. Scales of SF‐36.
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There are also two other less common instruments evaluating general health status: EuroQoL, 
5D (EQ‐5D) and Sickness Impact Profile (SIP). We preferred to mention about the most widely 
used questionnaires to give information related to ingredients and general aspects of them.
7.2. Disease‐specific instruments
Disease‐specific surveys evaluate factors associated with specific diseases and effect of treat‐
ment. In this way, the sensitivity in treatment options and outcomes can increased in com‐
parison with generic instruments, for evaluating QoL in venous diseases [56]. There are four 
instruments specific to venous disease, which have been used and validated. For evaluat‐
ing venous diseases with full scope, the Chronic Venous Insufficiency Questionnaire (CIVIQ) 
and the Venous Insufficiency Epidemiological and Economic Study (VEINES) should be 
preferred, while the Aberdeen Varicose Vein Questionnaire (AVVQ) and the Charing Cross 
Venous Ulceration Questionnaire (CXVUQ) are suitable to address particular aspects of 
venous disease [67].
7.2.1. Chronic Venous Insufficiency Questionnaire
Chronic Venous Insufficiency quality of life Questionnaire (CIVIQ) was developed in 
France to create a disease‐specific QoL instrument should be preferred in place of the 
generic QoL instruments [68]. Owing to psychometric evaluations and linguistic validity 
in many countries, it has been the most widely used QoL instrument in venous diseases 
[66]. According to CEAP classification, the CIVIQ is more sensitive to evaluate QoL for 
patients in between C0 and C4 clinical grade, because the items in this questionnaire are 
developed to obtain outcomes about effect of particularly varicose veins and edema on 
QoL, not venous ulcers [41].
Since CIVIQ was developed, it has undergone some changes. In the first version of the CIVIQ, 
four areas may evaluate including physical, psychological, social and pain, which is accepted 
as having effect on QoL. There were different numbers of questions in each category, and this 
made it difficult to calculate a compound score [68]. Therefore, the idea that there is a need 
to correction in the CIVIQ is aroused. A new revised version of the questionnaire is named 
as the CIVIQ‐20, which allows weighting the categories equally to obtain a global score. 
Parameters Examples of questions Yes No
Pain I have pain at night
Energy I am tired all the time
Sleep I take pills to help me sleep
Physical mobility I can walk about only 
indoors
Social isolation I feel lonely
Table 3. Examples of questions from the NHP.
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Nevertheless, it is proved that both versions of the CIVIQ are valid, reliable and consistent for 
measuring QoL [68, 69]. The items are scored according to the five‐point Likert scale [70]. The 
items of CIVIQ are given in Table 4.
There is also the third version of the CIVIQ as CIVIQ‐14. The CIVIQ‐14 was designed to facili‐
tate its use in clinical areas with the factorial stability of its previous version [71]. It is built 
by removing 6 items and one dimension causing to the factorial instability in the CIVIQ‐20 
questionnaire. The 14 remaining items covered three dimensions as physical, pain and 
 psychological [72].
The data obtained with CIVIQ are entirely trustworthy in terms of reflecting the effects of 
the disease according to self‐reporting by the patient with CVD. The CIVIQ was shown to be 
reliable owing to having good internal consistency, reproducibility and responsiveness [73]. 
Unlike the AVVQ which are going to be mentioned later, it is more sensitive to making allow‐
ance for the more psychological effects on the QoL resulting from CVI [41].
Items of CIVIQ‐20 1 2 3 4 5
1. Intensity of pain in legs
2. Interferes with work or daily activities
3. Sleeping poorly
4. To stand for a long time
5. Climbing stairs
6. In crunching/kneeling
7. Walking briskly
8. Travelling by car/plane/bus
9. Doing housework
10. Going to parties
11. Performing sport activities
12. Feel on edge
13. Getting tired easily
14. Feel like a burden people
15. Feeling weaker and stiffer
16. Embarresment to show legs
17. Easily irritable
18. Impression of being disabled
19. Difficulty getting up in the morning
20. Do not feel like going out
Table 4. The items of CIVIQ.
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7.2.2. Venous Insufficiency Epidemiological and Economic Study
The Venous Insufficiency Epidemiological and Economic study (VEINES Qol/Sym) evaluates 
the epidemiology and outcomes of CVD [74]. Unlike the generic QoL questionnaires lacking 
determining detailed information and lower sensitivity for CVD, the purpose of the VEINES 
QoL/Sym is to present a whole picture of the effect of CVD in the lower limbs [41].
Through the agency of the VEINES, it is evaluated that QoL and symptoms in many condi‐
tions in CVD ranging from telangiectasia, varicose veins, skin changes, edema to leg ulcers 
[38]. Psychometric analyzes revealed that the questionnaire was valid and reliable, as well 
as manifests correlation with SF‐36 and clinical grading according to CEAP. Furthermore, it 
is stated that the questionnaire is reliable and valid for evaluating of QoL and symptoms in 
patients with acute deep vein thrombosis (DVT) [75].
The questionnaire includes 35 items in two categories as the VEINES quality‐of‐life question‐
naire (VEINES‐QoL) is containing 25 items for evaluating QoL, and the VEINES symptom ques‐
tionnaire (VEINES‐Sym) containing 10 items measuring symptoms of disease. With the VEINES 
QoL/Sym, physical symptoms can measured more effectively than psychological and social 
aspects especially in patients with lower limb venous disease ranging from uncomplicated vari‐
cose veins to DVT, and the higher scores are associated with the better QoL outcomes [75].
7.2.3. Aberdeen Varicose Vein Questionnaire
Aberdeen Varicose Vein Questionnaire (AVVQ) developed by the Garratt et al. [76] in 1993 as 
a patient‐based questionnaire for measuring especially varicose vein outcomes. It is more spe‐
cific for disease, particularly focuses on symptoms and questions related to varicose veins [41].
There are some issues that can examined by the AVVQ such as social situation and physical 
symptoms including pain, edema in lower limbs, venous ulcers, using compression therapy 
and the impact of varicose veins on routine activities. The questionnaire contains 13 questions 
and is scored from 0 to 100. The higher scores indicate more severe effect of disease (0 point—
no effect, 100 point—severe effect) [76]. It is demonstrated in a study matched the AVVQ 
scores with SF‐36 in the literature that there is significant correlation between the AVVQ and 
SF‐36 outcomes [77]. Additionally, there is evidence reporting the AVVQ is reliable, is asso‐
ciated with patient symptoms significantly, and is considered to be greater responsive and 
sensitive than generic QoL questionnaires [49].
Being short and easy to complete are some of advantages the AVVQ. It is particularly suit‐
able for assessment of uncomplicated varicose vein and outcomes of treatment. In addition, 
it allows measurement and evaluation of treatment effects on daily life, if it is used in combi‐
nation with generic questionnaires, such as the SF‐36 or NHP [41].
7.2.4. Specific Quality of life and Outcome Response—Venous
Specific Quality of life and Outcome Response Venous (SQOR‐V) is another disease‐specific 
questionnaire separated to five domains about emotional problems, appearance, and limita‐
tion in movements, physical discomfort and risk to health. It contains 46 questions that are 
based on patient reported symptoms not clinical signs [78].
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The SQOR‐V gives more sensitive assessment in functional impact of CVD in patients with 
the class C1–C3 according to CEAP classification system and was designed especially for this 
purpose. There is evidence that the SQOR‐V has a significant correlation with the AVVQ [78], 
but it should be pointed out that the AVVQ more sensitive than SQOR‐V in demonstrating 
ulceration, varicose veins and other skin changes resulted from CVD [79].
7.2.5. Charing Cross Venous Ulceration Questionnaire
The Charing Cross Venous Ulceration Questionnaire (CXVUQ) was developed to provide a 
reliable measure for QoL in patients with venous ulcers. Prior to development of the CXVUQ, 
there was not available any reliable questionnaire evaluating effect of venous ulcer on QoL 
and treatment outcomes [67].
7.2.6. Assessment of Burden in Chronic Venous Disease
Assessment of Burden in Chronic Venous Disease (ABC‐V) was developed by Guex to evalu‐
ate directly burden of disease caused by varicose veins. It is a specific tool for evaluating of 
disease severity and treatments outcomes [80].
8. Discussion
Patients suffering from CVD, causing such as leg ulcers, edema, venous stasis, venous hyper‐
tension, etc., are demonstrate worse QoL. This is resulted from sustained discomfort in 
effected area especially in lower limbs, pain, limited mobility and prolonged healing time. 
Furthermore, particular treatment options and their financial cost have a significant impact 
on QoL [81]. It has been preferred to determine the effects of disease and treatment methods 
on disease from the point of view of the patient, especially in recent years [67]. There are two 
ways to follow outcomes of effects of venous diseases. One of these is using patient‐perceived 
and reported QoL measurements, another one evaluating clinical signs and symptoms by the 
physician reports. It is reported that there are many definitions and measuring methods of 
QoL. Even so, it is defined that there are some key concepts of QoL, which include reliable 
assessment of the disease’s functional effect on daily life activity, focusing on the patient’s 
point of view and feelings, and a taking into account of physical, social and psychological 
issues [56].
There are many study investigated QoL in patients with CVI. In the study conducted by the 
dos Santos Crisóstomo et al. [82], using CIVIQ to evaluate effect of manual lymphatic drainage 
(MLD) on HRQoL and symptoms in patients with CVI, revealed that a four‐week period of 
MLD treatment, which comprised approximately 40 min duration sessions, provide improve‐
ment in CVI, especially in terms of clinical severity of disease mostly associated with edema, 
symptoms and pain HRQoL. Furthermore, thanks to this research, it was demonstrated that 
the MLD had good effect on CVI and pain HRQoL, and it could still be observed after only 
4 weeks of follow‐up. On the other hand, it was found that MLD has not any changing effect 
on the physical, social, or psychological components of HRQOL. Another study carried out by 
Molski et al. [83] reported that MLD decreased the clinical severity of disease and lower limb 
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volume in patients with CVD, and improved QoL. They also reported that if MLD was started 
in the preoperative period, there would have been better improvement in quality of life.
Patients with venous ulcers are known as having poor HRQoL [84, 85], and there is a global 
concern about the link between HRQoL and venous ulcers. For defining health policies, 
obtaining information about clinical outcomes and determining effect of venous ulceration 
emerged that the importance of studying by HRQoL in patients with venous ulceration [85]. 
In a study investigating the relationship between venous ulcer and HRQoL, González de la 
Torre et al. [86] reported that venous ulcers had negative effect on patients’ HRQoL, especially 
in their emotional status. Additionally, the association with the degree of the wound and 
decreased HRQoL was found in the study. In another study carried out by Birks et al. [87], it 
is reported that generic questionnaires were reasonably well to measure HRQoL in patients 
with venous leg ulcers.
As mentioned before in this chapter, there are some disease specific questionnaires to mea‐
sure QoL, and each has some advantages and limitations. Kuet et al. [79] conducted a study 
to evaluate the relationship between the AVVQ and the CIVIQ‐14. Their purpose was to 
compare disease‐specific QoL tools with generic QoL and clinician‐driven tools. They used 
the AVVQ, CIVIQ‐14 and EQ‐5D to measure QoL, and CEAP classification and the VCSS to 
obtain information about severity of disease. In conclusion, it is reported that there was a 
strong correlation between the two disease‐specific QoL (the AVVQ and CIVIQ‐14). There 
was a significant correlation also found between these disease‐specific QoL questionnaires 
and the generic QoL (EQ‐5D). Furthermore, there was existed a strong relationship between 
the clinical scoring system and disease‐specific QoL questionnaires.
There is many factors effect QoL, and evidences demonstrate increasingly significant correla‐
tion between questionnaires and clinical severity of disease. Shepherd et al. [78] carried out a 
study in patients undergoing treatment for symptomatic veins to investigate the relationships 
between clinical severity of disease and QoL. Assessments were applied by using CEAP and 
VCSS to evaluate severity of disease, and SF‐12 (generic), the AVVQ (disease‐specific) and the 
Specific Quality of life and Outcome Response‐Venous (SQOR‐V) questionnaires to measure 
QoL. As a result, strong positive correlation was found between the AVVQ and the SQOR‐V. 
In addition, the correlation between the AVVQ to SF‐12 and the VCSS also was found statisti‐
cally significant.
As mentioned, venous disorders demonstrate a lot of clinical condition, which are effect indi‐
vidual in many ways. Post‐thrombotic syndrome (PTS) is one of a widespread clinical condi‐
tion seen in patients especially after deep venous thrombosis (DVT) and is characterized with 
symptoms such as pain, edema and skin changes [88]. Effect of PTS on the QoL has been inves‐
tigated for years and decreased QoL in patients developed PTS and is demonstrated in many 
studies [89, 90]. Furthermore, in patients having prior DVT history, QoL and clinical severity 
of disease are worse in comparison with patients having other forms of CVD [91]. Broholm 
et al. [90] found that PTS was associated with worse both in disease‐specific (measured with 
VEINES‐QOL/Sym) and generic (measured with SF‐36) QoL. In addition, they stated that 
there was a significant negative correlation between PTS and the VEINES‐QOL/Sym scales.
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The fact that increased clinical degree of venous disease was commonly associated with dete‐
riorating health outcomes and QoL has been proven by many studies. Carradice et al. [92] 
in their study which is conducted with the aim of to explore the impact of venous disease, 
and assess any gradual direct effect of clinically advanced disease on HRQoL, evaluated 561 
patients with the having different clinical degree of venous disease according to CEAP clinical 
grade. From those, 456 patients had C2–6 and 105 patients had C0–1 clinical degree, which is 
assumed as a control group. They also used VCSS system to determine severity of disease. To 
evaluate QoL, they use SF‐36 and EQ‐5D as generic instruments, and the AVVQ as a disease‐
specific instrument. As a result, they reported that there was a significant correlation between 
severity of disease and deterioration in both disease‐specific and generic QoL for all clinical 
grades, in particular in patients with more severe grade had worse QoL scores.
In conclusion, chronic venous disorders are globally common problem, and with the clinical 
properties, it has great impact on the QoL. To know how disease affects patient’s quality of life, 
and whether there will be any change in the condition of disease in the course of the treatment, it 
is essential to use valid and reliable disease‐specific assessment tools when patients are evaluated 
by the clinician. Therefore, it should not be considered only physical findings, when evaluating 
changes in the state of the disease, but also patient’s satisfaction and sense of well‐being should be 
assessed. Through the evaluation of all physical and mental aspects of the disease, the effective‐
ness of treatment outcomes and changes in burden of disease can be assessed more objectively.
To determine level of QoL, there are some general and disease‐specific questionnaires, which 
are developed particularly for patients with venous disorders. The SF‐36 and the NHP are 
most widely used to determine QoL both in patients and healthy population. However, it is 
proved that using disease‐specific questionnaires is more sensitive and reliable for measuring 
QoL in patients with CVD. The negative effect of CVD on the QoL has been proved in many 
studies by using different disease‐specific instruments, but there is not any consensus which 
questionnaire is the best among them. The CIVIQ, VCSS, AVVQ, SQOR‐V and CXVUQ are 
mostly used for evaluation QoL in patients having venous disease, and all are sensitive in 
detecting QoL levels specifically for venous diseases.
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